Successful treatment of factor H-related haemolytic uraemic syndrome

被引:24
作者
Stratton, JD [1 ]
Warwicker, P [1 ]
机构
[1] Lister Hosp, Stevenage SG1 4AB, Herts, England
关键词
D O I
10.1093/ndt/17.4.684
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:684 / 685
页数:2
相关论文
共 8 条
[1]   Familial hemolytic uremic syndrome associated with complement factor H deficiency [J].
Landau, D ;
Shalev, H ;
Levy-Finer, G ;
Polonsky, A ;
Segev, Y ;
Katchko, L .
JOURNAL OF PEDIATRICS, 2001, 138 (03) :412-417
[2]  
Noris M, 1999, J AM SOC NEPHROL, V10, P281
[3]   Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H - Original article [J].
Ohali, M ;
Shalev, H ;
Schlesinger, M ;
Katz, Y ;
Kachko, L ;
Carmi, R ;
Sofer, S ;
Landau, D .
PEDIATRIC NEPHROLOGY, 1998, 12 (08) :619-624
[4]   INHIBITION OF COMPLEMENT ACTIVATION BY INTRAVENOUS IMMUNOGLOBULINS [J].
QI, M ;
SCHIFFERLI, JA .
ARTHRITIS AND RHEUMATISM, 1995, 38 (01) :146-146
[5]   THE HEMOLYTIC-UREMIC SYNDROME [J].
REMUZZI, G ;
RUGGENENTI, P .
KIDNEY INTERNATIONAL, 1995, 48 (01) :2-19
[6]  
Sim R B, 1993, Int Rev Immunol, V10, P65, DOI 10.3109/08830189309051172
[7]   Factor H-US? [J].
Warwicker, P ;
Goodship, JA ;
Goodship, THJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (08) :1921-1923
[8]   Factor H and disease: a complement regulator affects vital body functions [J].
Zipfel, PF ;
Hellwage, J ;
Friese, MA ;
Hegasy, G ;
Jokiranta, ST ;
Meri, S .
MOLECULAR IMMUNOLOGY, 1999, 36 (4-5) :241-248